Amin Rostami-Hodjegan. Professor of Systems Pharmacology, University of Manchester, UK. Verified email at manchester.ac.uk - Homepage. Translational Modelling in Drug

2012 Jun 1;51(6):365-96. Jun 2012. Other authors. Penny Furness; Trevor N. Johnson; Amin Rostami-Hodjegan; Hora Soltani. See publication External link

In Vitro dissolution profiles (n=3) of nifedipine IR capsule in FaSSGF. FaSSGFst=FaSSGF at pH 1.6 with water, FaSSGFoj=FaSSGF at pH 3.4 with grapefruit juice 2014, Pocket/Paperback. Köp boken Biosimulation in Biomedical Research, Health Care and Drug Development hos oss! Jill Barber, Matthew R. Russell, Amin Rostami-Hodjegan, Brahim Achour. Characterization of CYP2B6 K262R allelic variants by quantitative allele-specific proteomics using a QconCAT standard. Journal of Pharmaceutical and Biomedical Analysis 2020, 178 , 112901.

Amin rostami-hodjegan

PubMed PMID: 27506526. 11: Chen R, Rostami-Hodjegan A, Wang H, Berk D, Shi J, Hu P. Application of a physiologically based pharmacokinetic model for the evaluation of single-point plasma phenotyping method of CYP2D6. Amin Rostami-Hodjegan Hartmut Derendorf (2010 – 2020) Oliver von Richter (2010 – 2018) Amin Rostami-Hodjegan, Professor of Systems Pharmacology, University of Manchester Amin is a Professor of Systems Pharmacology at the Centre for Applied Pharmacokinetic Research (CAPKR) in the School of Pharmacy and Pharmaceutical Sciences at the University of Manchester. He has an active program of training PhD students in Address correspondence and reprint requests to Dr. Amin Rostami-Hodjegan, Molecular Pharmacology and Pharmacogenetics, Floor L, The Royal Hallamshire Hospital, Sheffield S10 2JF, UK. E-mail: a.rostami@sheffield.ac.uk. FAST BREAKING PAPERS - 2008 April 2008 Amin Rostami-Hodjegan talks with ScienceWatch.com and answers a few questions about this month's Fast Breaking Paper in the field of Pharmacology & Toxicology.

Amin Rostami-Hodjegan, Professor of Systems Pharmacology, University of Manchester. Amin is a Professor of Systems Pharmacology at the Centre for Applied Professor Rostami is the Senior Vice President of Research & Development and Chief Scientific Officer at Certara.

Amin Rostami-Hodjegan is Chief Scientific Officer at Certara USA, Inc. View Amin Rostami-Hodjegan’s professional profile on Relationship Science, the database of decision makers.

Häftad, 2014. Skickas inom 10-15 vardagar.

Hajar Al Feteisi, Brahim Achour, Amin Rostami-Hodjegan, Jill Barber, Translational value of liquid chromatography coupled with tandem mass spectrometry-based quantitative proteomics for in vitro – in vivo extrapolation of drug metabolism and transport and considerations in selecting appropriate techniques , Expert Opinion on Drug Metabolism & Toxicology, 10.1517/17425255.2015.1055245, 11, 9

3Department of Pharmacology and Therapeutics (A.R.H., G.T.T.), Royal Hallamshire Hospital, Sheffield, in Biomedical Research, Health Care and Drug Development [Elektronisk resurs] / edited by Erik Mosekilde, Olga Sosnovtseva, Amin Rostami-Hodjegan. Författare: Erik Mosekilde, Olga Sosnovtseva, Amin Rostami-Hodjegan; Format: Pocket/Paperback; ISBN: 9783709117644; Språk: Engelska; Antal sidor: 396 Köp Biosimulation in Biomedical Research, Health Care and Drug Development av Erik Mosekilde, Olga Sosnovtseva, Amin Rostami-Hodjegan på Bokus.com.

演者： Amin Rostami-Hodjegan （Centre for Applied Pharmacokinetic Research, University of Manchester, UK ／Certara, Princeton, New Jersey, USA.）トランスポーターDISシンポジウム（シンポジウム12） 12月12日（木）13:45～15:45 D会場（大会議室101） Amin Rostami-Hodjegan,∇, Imran Shah, Martin F. Wilks,§ and Shana J. Sturla*,¶ †Center for Alternatives to Animal Testing (CAAT), Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland 21205, United States ‡University of Konstanz, CAAT-Europe, 78457 Konstanz, Germany Amin Rostami-Hodjegan, PharmD, PhD. Dr. Rostami-Hodjegan is a Professor of Systems Pharmacology at the Centre for Applied Pharmacokinetic Research (CAPKR) in the School of Pharmacy and Pharmaceutical Sciences at the University of Manchester. Model-informed precision dosing (MIPD) has become synonymous with modern approaches for individualizing drug therapy, in which the characteristics of each patient are considered as opposed to applying a one-size-fits-all alternative. This review provides a brief account of the current knowledge, pra … In vivo enzyme levels are governed by the rates of de novo enzyme synthesis and degradation. A current lack of consensus on values of the in vivo turnover half-lives of human cytochrome P450 (CYP) enzymes places a significant limitation on the accurate prediction of changes in drug concentration-tim … Amin Rostami-Hodjegan is Chief Scientific Officer at Certara USA, Inc. View Amin Rostami-Hodjegan’s professional profile on Relationship Science, the database of decision makers. As a direct-acting inhibitor of CYP2C19 in vitro, lansoprazole is more potent than omeprazole and other proton pump inhibitors (PPIs), but lansoprazole does not cause clinically significant inhibition of CYP2C19 whereas omeprazole does. To investigate this apparent paradox, we evaluated omeprazole, esomeprazole, R -omeprazole, lansoprazole, and pantoprazole for their ability to function as amin.rostami@manchester.ac.uk; Centre for Applied Pharmacokinetic Research (CAPKR), University of Manchester, UK, and Certara, Princeton, New Jersey, USA. Correspondence: Amin Rostami‐Hodjegan (amin.rostami@manchester.ac.uk)Search for more papers by this author Amin Rostami-Hodjegan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
Casino italian hot dog

Redaktör, Mosekilde, Erik. Redaktör, Sosnovtseva, Olga.

This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO). amin.rostami@manchester.ac.uk; Centre for Applied Pharmacokinetic Research (CAPKR), University of Manchester, UK, and Certara, Princeton, New Jersey, USA. Correspondence: Amin Rostami‐Hodjegan (amin.rostami@manchester.ac.uk)Search for more papers by this author 2011-11-01 Pris: 1769 kr. Häftad, 2014.
Advocate seldom seen

Amin Rostami-Hodjegan is the author of ADME (0.0 avg rating, 0 ratings, 0 reviews, published 2009) and Biosimulation in Biomedical Research, Health Care

Amin Rostami-Hodjegan,∇, Imran Shah, Martin F. Wilks,§ and Shana J. Sturla*,¶ †Center for Alternatives to Animal Testing (CAAT), Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland 21205, United States ‡University of Konstanz, CAAT-Europe, 78457 Konstanz, Germany 2007-02-01 · Amin Rostami-Hodjegan & Geoffrey T. Tucker. Authors. Amin Rostami-Hodjegan. View author publications.